Cargando…
The mutation profiles of cell-free DNA in patients with oesophageal squamous cell carcinoma who were responsive and non-responsive to neoadjuvant chemotherapy
BACKGROUND: The aim of this study was to evaluate the clinical value of plasma cell-free DNA (cfDNA) mutation profiles in patients with oesophageal squamous cell carcinoma (OSCC) who received neoadjuvant chemotherapy. METHODS: Twenty-two OSCC patients received neoadjuvant chemotherapy and were divid...
Autores principales: | Zhang, Ruixiang, Hu, Ying, Zhou, Tao, Han, Wenbo, Liu, Yang, Qian, Juanjuan, Chen, Yanhui, Liu, Xianben, Liu, Shilei, Yu, Yongkui, Zeng, Hui, Zhang, Henghui, Li, Yin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475527/ https://www.ncbi.nlm.nih.gov/pubmed/32944339 http://dx.doi.org/10.21037/jtd-20-230 |
Ejemplares similares
-
The Role of Adjuvant Chemotherapy in the Treatment of Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemotherapy
por: Li, Keting, et al.
Publicado: (2023) -
Reevaluation of Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma: A Meta-Analysis of Randomized Controlled Trials Over the Past 20 Years
por: Zheng, Yan, et al.
Publicado: (2015) -
Neoadjuvant chemotherapy followed by minimally invasive esophagectomy versus primary surgery for management of esophageal carcinoma: a retrospective study
por: Zheng, Yan, et al.
Publicado: (2019) -
Neoadjuvant Chemotherapy Compared with Surgery for Oesophageal Carcinoma: A Retrospective Study and Missing Evidence
por: Zheng, Yan, et al.
Publicado: (2023) -
Clinical Response to Neoadjuvant Immunotherapy Combined with Targeted Therapy and Chemotherapy in Oral Squamous Cell Carcinoma: Experience in Three Patients
por: Tian, Yu, et al.
Publicado: (2022)